Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review

• Zintzalas E.
• Vulgarelis M.
• Musopoulos HM

The risk of developing lymphoma in autoimmune diseases: a meta-analysis.

Arch Intern Med. 2005; 165: 2337-2344

Autoimmunity and lymphomagenesis.

Int J Cancer. 2009; 124: 1497-1502

• Rostami S.
• Hoff M.
• Brown MA
• and others.

Prediction of ankylosing spondylitis in HUNT studies with a genetic risk score combining 110 single-nucleotide polymorphisms of significance across the genome.

J Rheumatism. 2020; 47: 204-210

• International Genetics of the Ankylosing Spondylitis Consortium

Identification of multiple risk variants for ankylosing spondylitis by high-density genotyping of immune-related loci.

Nat June. 2013; 45: 730-738

• Chowdrefson B.
• Galeson AJ
• Bjornsson S.
• Bjarnason I.

Common genetic background of inflammatory bowel disease and ankylosing spondylitis: A genealogical study in Iceland.

Arthritic rheumatism. 2007; 56: 2633-2639

• Mierants H.
• Vais EM
• Cuvelier C.
• De Vos M.
• Botelberge L.

HLA-B27-associated arthritis and intestinal inflammation, Part 2: Ilecolonoscopy and intestinal histology in patients with HLA-B27-associated arthritis.

J Rheumatism. 1985; 12: 294-298

• Beaujerie L.
• Bulls N.
• Bouvier AM
• and others.
• CESAME Study Group

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

lancet. 2009; 374: 1617-1625

• Afif W.
• Sandborn WJ
• Forbion WA
• and others.

Lymphoma risk factors in patients with inflammatory bowel disease: a case-control study.

Inflammatory bowel disease. 2013; 19: 1384-1389

• Pedersen N.
• Durikova D.
• Elkyer M.
• Gumborg M.
• Munkholm P.
• Jess T.

Extraintestinal cancer risk in inflammatory bowel disease: a meta-analysis of population-based cohort studies.

J digestive system. 2010; 105: 1480-1487

• Fertelius N.
• Ekbom A.
• Bronqvist P.

Cancer incidence in patients with ankylosing spondylitis in Sweden from 1965 to 1995: a population-based cohort study.

An Reum Dis. 2003; 62: 1185-1188

• Becker N.
• Deeg E.
• Rudiger T.
• Nieters A.

Lymphoma history and risk: results of a population-based case-control study in Germany.

Eur J Cancer. 2005; 41: 133-142

• Askling J.
• Clarescog L.
• Bronqvist P.
• Ford M.
• Fertelius N.

Risk of malignant lymphoma in ankylosing spondylitis: a Swedish national case-control study.

An Reum Dis. 2006; 65: 1184-1187

• Rundgren O.
• Engels EA
• Pfeiffer RM
• and others.

Autoimmunity and susceptibility to Hodgkin’s lymphoma: a population-based case-control study in Scandinavia.

J National Cancer Institute. 2006; 98: 1321-1330

• Rundgren O.
• Lynette MS
• McMaster ML
• Gridley G.
• Haeminki K.
• goldin LR

Familial features of autoimmune and hematological disorders in 8,406 patients with multiple myeloma: a population-based case-control study.

Int J Cancer. 2006; 118: 3095-3098

• Rundgren O.
• Engels EA
• Caporazo NE
• and others.

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

blood. 2006; 108: 292-296

• Melemkiel L.
• Pfeiffer RM
• Engels EA
• and others.

Autoimmune disease in individuals and relatives, and susceptibility to non-Hodgkin’s lymphoma.

Arthritic rheumatism. 2008; 58: 657-666

• Brown LM
• Gridley G.
• Check D.
• Rundgren O.

Risk of Multiple Myeloma and Monoclonal Immunoglobulinemia of Undetermined Significance Among White and Black Male U.S. Veterans With Histories of Autoimmune, Infectious, Inflammatory, and Allergic Diseases .

blood. 2008; 111: 3388-3394

• Anderson LA
• Gadala S.
• Morton LM
• and others.

Population-based studies of autoimmune conditions and risk of certain lymphoid malignancies.

Int J Cancer. 2009; 125: 398-405

• Anderson LA
• Pfeiffer RM
• Rundgren O.
• Gadala S.
• Bernd SI
• Engels EA

Risk of myeloid malignancies in patients with autoimmune conditions.

Br J Cancer. 2009; 100: 822-828

• Lindqvist EK
• goldin LR
• Rundgren O.
• and others.

A personal and family history of immune-related disease increases the risk of plasma cell disorders: a population-based study.

blood. 2011; 118: 6284-6291

• Haeminki K.
• Ryu X.
• Felsty A.
• The J.
• Sunquist J.
• Sunquist K.

Impact of autoimmune disease on subsequent multiple myeloma incidence and survival.

J Hematol Oncol. 2012; Five: 59

• Haeminki K.
• Ryu X.
• Felsty A.
• The J.
• Sunquist J.
• Sunquist K.

Subsequent leukemia in patients with autoimmune disease.

Br J Hematol. 2013; 161: 677-687

• Farrah M.
• Ryu X.
• The J.
• Felsty A.
• Sunquist K.
• Haeminki K.

Autoimmune diseases associated with non-Hodgkin’s lymphoma: a national cohort study.

Ann Ongol. 2014; twenty five: 2025-2030

• Hellgren K.
• Smedby KE
• Bucklin C.
• and others.

Ankylosing spondylitis, psoriatic arthritis, and malignant lymphoma risk: a cohort study based on national prospective data from Sweden.

Rheumatoid arthritis. 2014; 66: 1282-1290

• Farrah M.
• Ryu X.
• The J.
• Felsty A.
• Sunquist K.
• Haeminki K.

Hodgkin lymphoma after autoimmune disease by age at diagnosis and histologic subtype.

Ann Ongol. 2014; twenty five: 1397-1404

• Hellgren K.
• dryer l.
• Arkema EV
• and others.
• Dambio Institute

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registries.

An Reum Dis. 2017; 76: 105-111

• Sun L.-M.
• Muo C.-H.
• Liang J.-A.
• Chan S.-N.
• Sung F.-C.
• Kao C.-H.

Increased cancer risk in patients with ankylosing spondylitis: a national population-based retrospective cohort study.

Scan J Rheumatism. 2014; 43: 301-306

• Chang C.-C.
• Chan C.-W.
• Nguyen P.-AA
• and others.

Ankylosing spondylitis and cancer risk.

on corlette. 2017; 14: 1315-1322

• Chang T.-M.
• Luo S.-F.
• Yu K.-H.
• See L.-C.
• Yellow L.-H.
• Kuo C.-F.

Cancer risk in patients with ankylosing spondylitis: a national cohort study from Taiwan.

Scan J Rheumatism. 2021; 50: 132-138

• Nam B.
• Kim H.
• Zhang Yizhi
• Cho S.-K.
• Sung Y.-K.
• Kim T.-H.

Malignant risk in Korean male patients with ankylosing spondylitis.

Rheumatism International. 2019; 39: 1741-1748

• Bispo JA
• Pinheiro PS
• Cobbets EK

Epidemiology and etiology of leukemia and lymphoma.

Cold Spring Herb Perspective Med. 2020; Ten: a034819

• Yang X.
• Chen H.
• Mann J.
• and others.

Time trends in incidence and survival rates for all leukemia types in the United States from 1975 to 2017.

J cancer. 2021; 12: 2326-2335

Epidemiology of Axial Spondyloarthritis: An Update.

Curr Opin rheumatism. 2018; 30: 137-143

• Dubreuil M.
• Perroquin C.
• Zhang Y.
• Choi HK
• Inman RD
• Neogi T.

Validity of ankylosing spondylitis diagnosis in The Health Improvement Network.

Pharmacoepidemiol Drug Saf. 2016; twenty five: 399-404

• Brandenburg NA
• Phillips S.
• Wells KE
• and others.

Validation of an algorithm in multiple myeloma based on administrative data using the SEER tumor registry and medical record review.

Pharmacoepidemiol Drug Saf. 2019; 28: 256-263

• Sia Am
• Curtis LH
• Hamill BG
• Dimartino LD
• Abernethy AP
• Shulman KA

The Medicare Modernization Act of 2003 and its association with patient wait times and travel distances for chemotherapy.

jam. 2008; 300: 189-196

• Setoguchi S.
• Solomon DH
• Glynn RJ
• Cook EF
• Levin R.
• Schneweiss S.

Concordance of diagnoses and dates of hematological malignancies and solid tumors between Medicare claims and cancer registry data.

Cancer causes control. 2007; 18: 561-569

Accuracy of diagnosis of inflammatory arthritis in the managed hospitalization database.

Pharmacoepidemiol Drug Saf. 2021; 30: 257-265

• Chedani H.
• Dorshe L.
• Fumery M.
• and others.

Cancer in geriatric-onset inflammatory bowel disease: a population-based study.

J digestive system. 2016; 111: 1428-1436

• Bernstein CN
• Blanchard JF
• Kliewer E.
• Waida A.

Cancer risk in patients with inflammatory bowel disease: a population-based study.

cancer. 2001; 91: 854-862

• Ye X.
• Kasaklang N.
• Mahmoud SM

Use of nonsteroidal anti-inflammatory drugs and risk of non-Hodgkin’s lymphoma: a systematic review and meta-analysis.

Hematol Oncol. 2015; 33: 176-186

• Reebaud M.
• Larson MC
• thompson, california
• and others.

Aspirin and other nonsteroidal anti-inflammatory drugs, statins, and the risk of non-Hodgkin’s lymphoma.

Int J Cancer. 2021; 149: 535-545

• Rainier G.
• Rainier JC
• Garden Bath Pan M.
• Schvaye A.
• Boisson M.
• frez d.

Ankylosing spondylitis and monoclonal immunoglobulinemia.

An Reum Dis. 1992; 51: 951-954

• Wendling D.
• Platy C.
• Berthelot J.-M.
• Claude Pierre P.
• Pham T.

Spondyloarthritis and monoclonal immunoglobulinemia.

Articular bone spine. 2012; 79: 327-329

Ionizing radiation as a risk factor for lymphoma: a review.

J Radiol Prot. 2020; 40: R151-R185

• Zhang J.
• Xie F.
• Delzel E.
• and others.

Trends in the use of biologics in rheumatoid arthritis patients enrolled in the U.S. Medicare program.

Arthritis Careless (Hoboken). 2013; 65: 1743-1751